These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 5363246)

  • 1. Exchange of IgM and albumin between plasma and synovial fluid in rheumatoid arthritis.
    Brown DL; Cooper AG; Bluestone R
    Ann Rheum Dis; 1969 Nov; 28(6):644-51. PubMed ID: 5363246
    [No Abstract]   [Full Text] [Related]  

  • 2. IgM class immunoglobulin with high rheumatoid factor activity interferes with the measurement of interleukin 1 beta.
    Carroll GJ; Bell MC
    J Rheumatol; 1991 Aug; 18(8):1266-9. PubMed ID: 1941841
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo synthesis of IgG by rheumatoid synovium.
    Sliwinski AJ; Zvaifler NJ
    J Lab Clin Med; 1970 Aug; 76(2):304-10. PubMed ID: 5434008
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparative study of the protein pattern in serum and synovial fluid.
    Willumsen L; Friis J
    Scand J Rheumatol; 1975; 4(4):234-40. PubMed ID: 1198078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synovial fluid copper and related variables in rheumatoid and degenerative arthritis.
    Scudder PR; McMurray W; White AG; Dormandy TL
    Ann Rheum Dis; 1978 Feb; 37(1):71-2. PubMed ID: 629608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between rheumatoid factor and IL-6 activity in synovial fluids from patients with rheumatoid arthritis.
    Sawada T; Hirohata S; Inoue T; Ito K
    Clin Exp Rheumatol; 1991; 9(4):363-8. PubMed ID: 1934684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in sodium salicylate protein binding in serum and synovial fluid from patients with a knee effusion.
    Caillier I; Bannwarth B; Monot C; Lapicque F; Netter P; Gaucher A; Royer RJ
    Int J Clin Pharmacol Ther Toxicol; 1990 Jan; 28(1):7-13. PubMed ID: 2303312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The penetration of ceftriaxone into synovial fluid of the inflamed joint.
    Morgan JR; Paull A; O'Sullivan M; Williams BD
    J Antimicrob Chemother; 1985 Sep; 16(3):367-71. PubMed ID: 4055544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative investigation of protein concentration in serum and synovial fluid.
    Veys EM
    Scand J Rheumatol; 1974; 3(1):1-12. PubMed ID: 4138128
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma and synovial fluid kinetics of flurbiprofen in rheumatoid arthritis.
    Aarons L; Salisbury R; Alam-Siddiqi M; Taylor L; Grennan DM
    Br J Clin Pharmacol; 1986 Feb; 21(2):155-63. PubMed ID: 3954931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolism of autologous IgM and 19S rheumatoid factor in rheumatoid arthritis.
    Bradley J; Normansell D; Rowe DS
    Clin Exp Immunol; 1969 May; 4(5):537-53. PubMed ID: 5787345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some observations and speculations on the factors influencing the concentration of phenylbutazone in synovial fluid.
    Farr M; Hawkins CF; Kendall MJ; Willis JV
    Int J Clin Pharmacol Ther Toxicol; 1982 Dec; 20(12):589-94. PubMed ID: 7152741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disappearance kinetics of solutes from synovial fluid after intra-articular injection.
    Owen SG; Francis HW; Roberts MS
    Br J Clin Pharmacol; 1994 Oct; 38(4):349-55. PubMed ID: 7833225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease.
    Zubler RH; Nydegger U; Perrin LH; Fehr K; McCormick J; Lambert PH; Miescher PA
    J Clin Invest; 1976 May; 57(5):1308-19. PubMed ID: 944196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of salicylate binding to synovial fluid and plasma protein in patients with rheumatoid arthritis.
    Trnavská Z; Trnavský K
    Eur J Clin Pharmacol; 1980 Nov; 18(5):403-6. PubMed ID: 7439262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of piroxicam to synovial fluid and plasma proteins in patients with rheumatoid arthritis.
    Trnavská Z; Trnavský K; Zlnay D
    Eur J Clin Pharmacol; 1984; 26(4):457-61. PubMed ID: 6734706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration of azapropazone in synovial tissues and fluid.
    Spahn H; Thabe K; Mutschler E; Tillmann K; Gikalov I
    Eur J Clin Pharmacol; 1987; 32(3):303-7. PubMed ID: 3595703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and laboratory parameters which affect soluble interleukin-2 receptor levels in the serum and synovial fluids of patients with rheumatoid arthritis.
    Matsumoto T; Iwasaki K
    Ann Rheum Dis; 1993 Dec; 52(12):876-80. PubMed ID: 8311539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-penicillamine and D-penicillamine-protein disulphide in plasma and synovial fluid of patients with rheumatoid arthritis.
    Joyce DA; Day RO
    Br J Clin Pharmacol; 1990 Oct; 30(4):511-7. PubMed ID: 2291865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on changes of the electrophoretic distribution of protein fraction in serum and synovial fluid in rheumatoid arthritis.
    Uchida T
    Kumamoto Igakkai Zasshi; 1971 Dec; 45(12):1089-123. PubMed ID: 5172595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.